Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)
ISIN: INE048B01027 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
310.6
7.35(2.42%)

Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health, pain and analgesics, and general medicine. It offers general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products; and women's healthcare products, including pregnancy care, and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management, and bone and joint care. It offers drugs in the form of tablets, capsules, and syrups. The company was founded in 1964 and is based in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.

Pricing Updates

TODAY'S HIGH

315.7

TODAY'S LOW

302.95

52 WEEK HIGH

369

52 WEEK LOW

123

Major Holders

% of Shares Held by
All Insider

77.68%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

813.70 Cr.

ETERPRISE VALUE

709.83 Cr.

NO. OF SHARES

2.61 Cr.

BOOK VALUE

52.342

DIV. YIELD

4%

DEBT

0

GROSS PROFIT

130.31 Cr.

CASH

48.29 Cr.

REVENUE

226.09 Cr.

REVENUE/SHARE

86.343

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-28.44 Cr.-4.17 Cr.-11.38 Cr.-11.38 Cr.
Change To Liabilities88.28 Lakhs18.28 Cr.-36.58 Lakhs2.76 Cr.
Total cashflows from Investing Activities-26.20 Cr.-2.26 Cr.-11.07 Cr.-82.59 Lakhs
Net Borrowings000-4.51 Cr.
Total Cash from Financing Activities-12.30 Cr.-6.82 Cr.-1.82 Cr.-6.05 Cr.
Other Liabilities-11.48 Cr.-5.79 Cr.2.73 Cr.-6.20 Cr.
Total Assets0000
Net Income19.58 Cr.17.05 Cr.7.87 Cr.7.21 Cr.
Change in Cash-32.91 Cr.19.12 Cr.-1.01 Cr.24.02 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities5.59 Cr.28.22 Cr.11.88 Cr.30.89 Cr.
Depreciation1.52 Cr.1.08 Cr.1.12 Cr.1.01 Cr.
Other Cashflows from Investing Activities2.70 Cr.2.37 Cr.2.16 Cr.1.42 Cr.
Dividends Paid-10.47 Cr.-2.62 Cr.-1.31 Cr.-65.50 Lakhs
Change to Inventory-1.76 Lakhs-39.95 Lakhs3.36 Cr.18.74 Cr.
Change to Account Receivables-2.91 Cr.8.78 Cr.-70.32 Lakhs4.40 Cr.
Other Cashflows from Financing Activities-28.51 Lakhs-51.35 Lakhs-51.41 Lakhs-88.01 Lakhs
Change to Net Income1.61 Cr.-1.51 Cr.-1.95 Cr.2.95 Cr.
Capital Expenditures-46.75 Lakhs-46.91 Lakhs-1.85 Cr.-2.25 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax27.31 Cr.21.87 Cr.9.41 Cr.9 Cr.
Minority InterestNoneNoneNoneNone
Net Income24.26 Cr.18.78 Cr.7.40 Cr.8.31 Cr.
Selling General Administrative57.67 Cr.68.08 Cr.68.73 Cr.48.25 Cr.
Gross Profit130.31 Cr.106.70 Cr.101.93 Cr.93.33 Cr.
Ebit24.26 Cr.18.78 Cr.7.40 Cr.8.31 Cr.
Operating Income24.26 Cr.18.78 Cr.7.40 Cr.8.31 Cr.
Other Operating Expenses46.84 Cr.18.75 Cr.24.67 Cr.35.74 Cr.
Interest Expense-28.51 Lakhs-42.75 Lakhs-38.31 Lakhs-44.43 Lakhs
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense7.73 Cr.4.81 Cr.1.54 Cr.1.78 Cr.
Total Revenue226.09 Cr.187.94 Cr.158.56 Cr.166.82 Cr.
Total Operating Expenses201.82 Cr.169.15 Cr.151.16 Cr.158.50 Cr.
Cost of Revenue95.78 Cr.81.23 Cr.56.63 Cr.73.48 Cr.
Total Other Income Expense Net3.05 Cr.3.08 Cr.2.01 Cr.68.35 Lakhs
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.19.58 Cr.17.05 Cr.7.87 Cr.7.21 Cr.
Net Income Applicable to Common Shares19.58 Cr.17.05 Cr.7.87 Cr.7.21 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets2.34 Cr.000
Capital Surplus060 Lakhs60 Lakhs60 Lakhs
Total Liabilities37.59 Cr.42.27 Cr.37.65 Cr.31.31 Cr.
Stock Holder Equity130.85 Cr.121.92 Cr.111.03 Cr.104.47 Cr.
Minority Interest0000
Other Liabilities17.37 Cr.6.62 Cr.9.78 Cr.11.68 Cr.
Total Assets168.45 Cr.164.20 Cr.148.69 Cr.135.78 Cr.
Common Stock13.09 Cr.13.09 Cr.13.09 Cr.13.09 Cr.
Retained Earnings0100.39 Cr.89.49 Cr.82.93 Cr.
Other Liabilities3.44 Cr.1.87 Cr.3.09 Cr.3.11 Cr.
Good Will3 Lakhs3 Lakhs3 Lakhs3 Lakhs
Treasury Stock117.75 Cr.7.83 Cr.7.83 Cr.7.83 Cr.
Other Assets12.35 Cr.8.29 Cr.17 Cr.14.68 Cr.
Cash26.15 Cr.58.94 Cr.39.81 Cr.7.58 Cr.
Current Liabilities34.15 Cr.40.39 Cr.34.56 Cr.28.19 Cr.
Long Term Asset Charges0000
Short Long Term Debt0000
Other Stockholder Equity117.75 Cr.7.83 Cr.7.83 Cr.7.83 Cr.
Property Plant Equipment22.37 Cr.23.34 Cr.23.96 Cr.23.50 Cr.
Total Cur. Assets110.77 Cr.120.47 Cr.96.30 Cr.97.55 Cr.
Long Term Investments20.57 Cr.12.05 Cr.11.38 Cr.5 k
Net Tangible Assets128.48 Cr.121.89 Cr.111 Cr.104.44 Cr.
Short Term Investments22.14 Cr.3.25 Cr.030.95 Cr.
Net Receivables15.89 Cr.14.46 Cr.22.81 Cr.21.27 Cr.
Long Term Debt0000
Inventory29.74 Cr.29.72 Cr.29.32 Cr.32.69 Cr.
Accounts Payable16.28 Cr.18.04 Cr.11.70 Cr.11.86 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account